JPMorgan Chase & Co. Raises Cardinal Health (NYSE:CAH) Price Target to $145.00

Cardinal Health (NYSE:CAH) had its price objective hoisted by investment analysts at JPMorgan Chase & Co. from $142.00 to $145.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 14.49% from the stock’s current price.

Other equities research analysts have also issued reports about the company. Citigroup increased their price target on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Barclays lifted their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and raised their price target for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Mizuho began coverage on Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 target price on the stock. Finally, UBS Group upped their price target on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $135.93.

Cardinal Health Trading Up 1.1 %

CAH stock traded up $1.32 during midday trading on Tuesday, hitting $126.65. The stock had a trading volume of 301,004 shares, compared to its average volume of 2,314,896. Cardinal Health has a 52 week low of $93.17 and a 52 week high of $132.84. The stock has a 50-day simple moving average of $122.11 and a 200 day simple moving average of $114.53. The firm has a market capitalization of $30.60 billion, a price-to-earnings ratio of 23.61, a P/E/G ratio of 1.46 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, equities analysts forecast that Cardinal Health will post 7.92 EPS for the current year.

Institutional Investors Weigh In On Cardinal Health

A number of large investors have recently added to or reduced their stakes in the stock. CHURCHILL MANAGEMENT Corp lifted its stake in Cardinal Health by 1.5% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock valued at $28,435,000 after purchasing an additional 3,576 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Cardinal Health by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after purchasing an additional 42,082 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Cardinal Health by 2.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after buying an additional 33,388 shares during the period. Alpha Cubed Investments LLC acquired a new stake in Cardinal Health in the third quarter valued at approximately $371,000. Finally, Patton Albertson Miller Group LLC acquired a new position in shares of Cardinal Health during the fourth quarter worth approximately $258,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.